La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Nanobiotix a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Nanobiotix..

Nanobiotix (NASDAQ:NBTX) Azioni, Catena delle Opzioni

Nanobiotix

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Nanobiotix SA

Earnings

Press Releases

Nanobiotix Provides First Quarter 2025 Operational and Financial Update

News

Health Care

NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference

Legal

General

NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)

Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

4 Biotech Stocks at the Cutting Edge of Drug Delivery (MDCX, RNA, NBTX, ARWR)

NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer

Small Cap

Opinion

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

ARWR

ENGN

GTBP

IMAB

MDCX

NBTX

ONCO

PARIS:NANO

Aurinia Pharmaceuticals Inc - Common Shares

Aurinia Pharmaceuticals

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharma

Biohaven

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Dianthus Therapeutics, Inc. - Common Stock

Dianthus Therapeutics

Immunocore Holdings plc - American Depositary Shares

Immunocore Holdings

Immunome

Immatics

Janux Therapeutics

MannKind

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Novavax

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Arcus Biosciences

Sionna Therapeutics

Syndax Pharmaceuticals, Inc. - Common Stock

Syndax Pharmaceuticals

Stoke Therapeutics

Spyre Therapeutics

Taysha Gene Therapies, Inc. - Common Stock

Taysha Gene Therapies

Twist Bioscience Corporation - Common Stock

Twist Bioscience

Vericel

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Zenas BioPharma

Zymeworks

Guggenheim

Leerink Partners

Comments

Nanobiotix

Nanobiotix (NBTX) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO